ANALYSIS OF PLATELET HEMOSTASIS IN PATIENTS ON THE BACKGROUND OF DUAL ANTIPLATELET THERAPY FOR 12 MONTHS

被引:0
|
作者
Kozachyshyn, Nataliia [1 ]
Netiazhenko, Vasyl [1 ]
Plenova, Olga [1 ]
Malchevska, Tetyana [1 ]
机构
[1] Bohomolets Natl Med Univ, Dept Propaedeut Internal Med 1, Kiev, Ukraine
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P531
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Noninferiority of 6 Versus 12 Months of Dual Antiplatelet Therapy
    Kaneda, Hideaki
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (21) : 2359 - 2359
  • [2] Dual antiplatelet therapy in patients with an acute coronary syndrome: up to 12 months and beyond
    Pareek, Manan
    Bhatt, Deepak L.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0B) : B21 - B28
  • [3] Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents? All Patients With Drug-Eluting Stents Need at Least 12 Months of Dual Antiplatelet Therapy Response
    Podrid, Philip J.
    [J]. CIRCULATION, 2015, 131 (22) : 2020 - 2020
  • [4] DUAL ANTIPLATELET THERAPY FOR 1 TO 3 MONTHS IS SUPERIOR TO 12 MONTHS AFTER CORONARY STENTING
    Knijnik, Leonardo Mees
    Fernandes, Marcelo
    Cardoso, Rhanderson
    Montanez-Valverde, Raul
    Maza, Manuel Rivera
    Goyal, Abhinav
    Liberman, Henry
    Cohen, Mauricio
    Sperling, Laurence
    McDaniel, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1071 - 1071
  • [6] Dual antiplatelet therapy duration in patients with ACS undergoing PCI: The "12 months tenet" is soundly questioned
    de la Torre Hernandez, Jose M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 284 : 12 - 13
  • [7] Platelet reactivity patterns in patients treated with dual antiplatelet therapy
    Winter, Max-Paul
    Schneeweiss, Theresia
    Cremer, Rolf
    Biesinger, Benedikt
    Hengstenberg, Christian
    Prueller, Florian
    Wallner, Markus
    Kolesnik, Ewald
    von Lewinski, Dirk
    Lang, Irene M.
    Siller-Matula, Jolanta M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (06)
  • [8] Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
    Serebruany, Victor L.
    Kim, Moo Hyun
    Cabrera-Fuentes, Hector A.
    Lee, Kwangmin
    Cho, Young Rak
    Park, Kyungil
    Park, Tae Ho
    Kim, Young Dae
    Yoon, Sung-Cheol
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (05) : 934 - 939
  • [9] 1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention Reply
    Watanabe, Hirotoshi
    Kimura, Takeshi
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1715 - 1716
  • [10] Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome The STOPDAPT-2 ACS Randomized Clinical Trial
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Yamamoto, Ko
    Obayashi, Yuki
    Ogita, Manabu
    Suwa, Satoru
    Isawa, Tsuyoshi
    Domei, Takenori
    Yamaji, Kyohei
    Tatsushima, Shojiro
    Watanabe, Hiroki
    Ohya, Masanobu
    Tokuyama, Hideo
    Tada, Tomohisa
    Sakamoto, Hiroki
    Mori, Hiroyoshi
    Suzuki, Hiroshi
    Nishikura, Tenjin
    Wakabayashi, Kohei
    Hibi, Kiyoshi
    Abe, Mitsuru
    Kawai, Kazuya
    Nakao, Koichi
    Ando, Kenji
    Tanabe, Kengo
    Ikari, Yuji
    Morino, Yoshihiro
    Kadota, Kazushige
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kimura, Takeshi
    [J]. JAMA CARDIOLOGY, 2022, 7 (04) : 407 - 417